Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)

NCT03414918 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Hyperaldosteronism

Interventions

DRUG: Clarithromycin

Sponsor

University Hospital Padova

Collaborators

[object Object]